WallStSmart
APM

Aptorum Group Ltd Class A

NASDAQ: APM · HEALTHCARE · BIOTECHNOLOGY

$0.83
-7.34% today

Updated 2026-06-05

Market cap
$8.71M
P/E ratio
P/S ratio
23.35x
EPS (TTM)
$-0.19
Dividend yield
52W range
$1 – $4
Volume
0.1M

Aptorum Group Ltd Class A (APM) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$0.00$0.00$383450.00$535166.00$911509.00$1.54M$1.30M$431378.00$0.00$0.00
Revenue growth (YoY)+39.6%+70.3%+69.2%-16.0%-66.7%-100.0%
Cost of revenue$0.00$58903.00$318011.00$794545.00$1.01M$1.46M$1.22M$420812.00$255046.00$0.00
Gross profit$0.00$-58903.00$65439.00$-259000.00$-104000.00$81854.00$80065.00$10566.00$-255000.00$0.00
Gross margin17.1%-48.4%-11.4%5.3%6.2%2.4%
R&D$2.56M$2.50M$3.10M$6.94M$11.59M$10.87M$9.22M$5.20M$1.94M$352879.00
SG&A$827588.00$2.88M$6.73M$10.78M$7.71M$8.03M$7.87M$4.37M$1.46M$1.64M
Operating income$-878234.00$-5.69M$-10.33M$-18.20M$-19.89M$-19.21M$-17.51M$-10.60M$-3.80M$-1.82M
Operating margin-2693.4%-3400.4%-2182.6%-1245.6%-1351.0%-2457.5%
EBITDA$-2.50M$-9.99M$-15.12M$6.50M$-25.83M$-10.32M$-9.48M$-3.76M$-1.82M
EBITDA margin-2606.3%-2824.9%712.9%-1675.0%-796.1%-2196.7%
EBIT$-878234.00$-2.56M$-10.68M$-16.42M$5.16M$-27.02M$-11.53M$-10.60M$-4.01M
Interest expense$0.00$0.00$4.46M$3.70M$243628.00$93601.00$146588.00$121145.00$146924.00$95713.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-2.13M$-2.55M$-14.83M$-18.69M$7.07M$-25.05M$-9.80M$-2.83M$-4.27M$-1.36M
Net income growth (YoY)-19.3%-482.3%-26.0%+137.8%-454.4%+60.9%+71.2%-51.1%+68.1%
Profit margin-3868.0%-3491.8%775.3%-1624.4%-756.2%-654.9%

Frequently asked questions

How much free cash flow does APM generate?

APM produced $-1.84M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is APM's balance sheet healthy?

APM holds $3.45M in cash and equivalents against — in long-term debt, on $23.12M of shareholder equity. That debt is best read against the cash flow the business throws off each year.